DocGo to Showcase America’s First All-Electric, Zero-Emissions Ambulance at the New York International Auto Show

162

Leading Mobile Health Services and Medical Transportation Innovator to Exhibit its First-of-its-kind Ambulance at the Renowned Auto Show’s EV Pavilion

NEW YORK--(BUSINESS WIRE)--DocGo, a leading provider of last-mile mobile health services and integrated medical mobility solutions (Nasdaq: DCGO), announced today that it will exhibit its new all-electric, zero-emissions ambulance at the New York International Auto Show, taking place at the Jacob K. Javits Convention Center on April 15-24, 2022. The first of its kind to be registered in the U.S., the vehicle emits just 10% of the pollutants as compared to a standard gasoline powered ambulance. At the show, hundreds of thousands of attendees will have the opportunity to see the vehicle in-person and speak with a DocGo representative to learn more about it.


A leading automobile exhibition for more than a century, the New York International Auto Show is a combination of new ideas, technological innovation, exceptional concept cars and the latest cars and trucks. This year, 250,000 square feet of the show will be dedicated to electric vehicles.

“As a New York-based company dedicated to sustainability, we are honored to be a part of the esteemed New York International Auto Show this year,” said DocGo President Anthony Capone. “We look forward to showcasing our new all-electric ambulance and encourage all attendees who are interested in the future of eco-friendly medical transportation to visit our exhibit.”

With a continued commitment to sustainability through its “Zero Emissions” initiative, DocGo aims to have an all-electric fleet by 2032.

In addition to participating in the NY International Auto Show, Ambulnz by DocGo also provides emergency medical services at the Jacob K. Javits Center.

DocGo is redefining on-demand access to healthcare, leveraging its AI-powered proprietary technology and expert healthcare professionals. The company delivers Mobile Health services at scale for hospital networks, governmental entities, and enterprise customers to provide high-quality, affordable care to patients when and where they need it most. DocGo's mobility solutions, enabled through coordinated logistics and focus on exceptional patient care, give patients much-needed access to medical attention outside of the traditional four walls of the medical establishment.

About DocGo
DocGo is a leading provider of last-mile mobile care services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.

Forward-Looking Statements
This announcement contains forward-looking statements (including within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and Section 27A of the U.S. Securities Act of 1933, as amended) concerning DocGo. These statements include, but are not limited to, statements that address our expected future business and financial performance and statements about (i) our plans, objectives and intentions with respect to future operations, services and products, (ii) our competitive position and opportunities, and (iii) other statements identified by words such as "may", "will", "expect", "intend", "plan", "potential", "believe", "seek", "could", "estimate", "judgment", "targeting", "should", "anticipate", "predict" "project", "aim", "goal", “outlook”, “guidance”, and similar words, phrases or expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as assumptions made by, and information currently available to, management, and current market trends and conditions. Forward-looking statements inherently involve risks and uncertainties, many of which are beyond our control, and which may cause actual results to differ materially from those contained in our forward-looking statements. Accordingly, you should not place undue reliance on such statements. Particular uncertainties that could materially affect current or future results include possible accounting adjustments made in the process of finalizing reported financial results; any risks associated with global economic conditions and concerns; the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks, such as the COVID-19 coronavirus pandemic; competitive pressures; pricing declines; rates of growth in our target markets; our ability to improve gross margins; cost-containment measures; legislative and regulatory actions; the impact of legal proceedings and compliance risks; the impact on our business and reputation in the event of information technology system failures, network disruptions, cyber-attacks, or losses or unauthorized access to, or release of, confidential information; and the ability of the company to comply with laws and regulations regarding data privacy and protection. We undertake no intent or obligation to publicly update or revise any of these forward-looking statements, whether as a result of new information, future events or otherwise.


Contacts

Media:
Janine Warner
Crowe PR
docgo@crowepr.com
646-916-5314

Investors:
Steve Halper
LifeSci Advisors
shalper@lifesciadvisors.com
ir@docgo.com
646-876-6455

Tutti i diritti riservati. E' vietata la diffusione
e riproduzione totale o parziale in qualunque formato degli articoli presenti sul sito.